Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001564076 | SCV001787179 | likely benign | not provided | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001564076 | SCV002063486 | likely benign | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458531 | SCV002737236 | likely benign | Inborn genetic diseases | 2018-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495900 | SCV002795784 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2022-01-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002573186 | SCV003015322 | likely benign | Rubinstein-Taybi syndrome | 2023-09-07 | criteria provided, single submitter | clinical testing |